1-Pyrroline-5-carboxylate released by prostate Cancer cell inhibit T cell proliferation and function by targeting SHP1/cytochrome c oxidoreductase/ROS Axis
Yutao Yan(First Affiliated Hospital of Jiangxi Medical College), Yonglian Guo(Aerospace Center Hospital), Hongzhe Tian(Second Military Medical University), Lei Chang(University of California San Diego), Lu Wang(Ningbo University), Tao Yang(Jiangsu University), Guohao Li(Central Hospital of Wuhan), Weifeng Hu(Zhejiang Chinese Medical University), Yawei Zhang(Yale University), Gang Chen(Tongji Hospital), Kavita Shah(Purdue University West Lafayette)
Cited by 79
Related Papers
United States Food and Drug Administration Drug Approval Summary
|Clinical Cancer Research|2004|500
Engineering unnatural nucleotide specificity for Rous sarcoma virus tyrosine kinase to uniquely label its direct substrates
|Proceedings of the National Academy of Sciences|1997|418
SPDEF is required for mouse pulmonary goblet cell differentiation and regulates a network of genes associated with mucus production
|Journal of Clinical Investigation|2009|401
Hepatitis C and Non-Hodgkin Lymphoma Among 4784 Cases and 6269 Controls From the International Lymphoma Epidemiology Consortium
|Clinical Gastroenterology and Hepatology|2008|336